Last reviewed · How we verify
BAX 826
At a glance
| Generic name | BAX 826 |
|---|---|
| Also known as | BAX826 |
| Sponsor | Baxalta now part of Shire |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BAX 826 CI brief — competitive landscape report
- BAX 826 updates RSS · CI watch RSS
- Baxalta now part of Shire portfolio CI